ELEKTA TO DELIVER FIRST LEKSELL GAMMA KNIFE® UNIT TO RUSSIA

ELEKTA TO DELIVER FIRST LEKSELL GAMMA KNIFE® UNIT TO RUSSIA

Burdenko Neurosurgical Institute in Moscow will add non-invasive brain

surgery to its range of advanced treatment methods

Recently, Elekta finalized the contract with Finance Leasing Company

(Moscow, Russia) and Neurosurgical Business Center (NBC) for Burdenko

Neurosurgical Institute to deliver Leksell Gamma Knife®, the gold

standard equipment for non-invasive Gamma Knife® surgery. This Leksell

Gamma Knife® unit is the first to be installed in Russia, serving a

previously unmet need for non-invasive treatment of small to medium size

intracranial lesions.

"We are very excited about the prospect of adding Leksell Gamma Knife®

to our advanced treatment methods here at Burdenko", says Dr. Nikolay

Alexandrovich Konovalov, Director of the Institute. "Continuing our

tradition of being at the forefront of microsurgery and minimally

invasive treatments, the addition of Gamma Knife® surgery will provide

us with a method to treat a variety of brain tumors, vascular

malformations and functional diseases that will be of great benefit to

our patients. The non-invasive technique of Gamma Knife® surgery offers

important benefits. We are in high demand for these treatments and I

expect a high patient volume on our Leksell Gamma Knife® unit", Dr

Konovalov concludes.

"Gamma Knife® surgery revolutionized the treatment of brain disorders

when it was introduced over thirty years ago. Today, the potential for

its use and the benefits that it brings are bigger than ever. It is with

great pride that we now are going to supply the first Leksell Gamma

Knife® unit to Russia", says Thomas Meyer von der Twer, Director of

European sales of neurosurgery products at Elekta, and continues: "It is

also an honor to welcome the esteemed Dr Konovalov and his colleagues to

Leksell Gamma Knife Society and to the sharing of experiences, new

results and solutions to clinical problems that to this day has produced

more than 2,000 scientific papers, documenting the results of various

treatments with Leksell Gamma Knife®".

To date, well over 250,000 patients around the world have been treated

with Leksell Gamma Knife®, and each year more than 30,000 new patients

are treated at the close to 200 units installed around the world.

The total payment for the Leksell Gamma Knife® unit to Burdenko

Neurosurgical Institute will amount to 3,8 MEUR. The order was booked by

Elekta in February.